Third Harmonic Bio Launches with $155M to Tackle Mast Cell-Driven Diseases | BioSpace

Retrieved on: 2022-02-16 18:33:46

Tags for this article:

Click the tags to see associated articles and topics

Third Harmonic Bio Launches with $155M to Tackle Mast Cell-Driven Diseases | BioSpace. View article details on hiswai:

Excerpt

This follows a $50 million Series A, led by Atlas Venture, which upstarted Third Harmonic Bio in 2019. Atlas was accompanied in that round by ...

Article found on: www.biospace.com